Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 2
This trial is looking at giving pembrolizumab after having paclitaxel for women with ovarian cancer that has come back after treatment.
It is open to women who have:
Treatment for these cancers is the same. So when we use ovarian cancer in the summary we are referring to all 3 cancers.
Recruitment start: 16 May 2019
Recruitment end: 8 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
University College London (UCL)
Merck, Sharp & Dohme
Cancer Research UK & UCL Cancer Trials Centre
Last reviewed: 20 January 2023
CRUK internal database number: 17202
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
